Experimental Neurology, a Journal of Neuroscience Research, publishes original research in neuroscience with a particular emphasis
on novel findings in neural development, regeneration, plasticity and transplantation. The journal has focused on research concerning
basic mechanisms underlying neurological disorders.
Since Sid Gilman, University of Michigan, took over ... click here for full Aims & Scope
Experimental Neurology, a Journal of Neuroscience Research, publishes original research in neuroscience with a particular emphasis
on novel findings in neural development, regeneration, plasticity and transplantation. The journal has focused on research concerning
basic mechanisms underlying neurological disorders.
Since Sid Gilman, University of Michigan, took over as Editor-in-Chief in
2003, Experimental Neurology has broadened and expanded dramatically into translational neuroscience. Experimental Neurology is now one
of the premier journals covering the basic science underlying both neurological and psychiatric disorders. Section editors have been
recruited from Europe as well as the US and rotated frequently to ensure that we have fresh, unbiased reviews. Current Section Editors
include Steven Goldman, Cellular and Molecular Neuroscience; Evan Snyder, Development; Eugene Johnson, Genetic Disorders and Trophic
Factors; James Geddes, Neural Systems; James Herman, Neuroendocrine and Homeostatic Mechanisms; Mathias Baehr, Neurological Disorders;
Ahmet Hoke, Peripheral Neuropathy and Pain; Isabella Heuser, Psychiatric Disorders; Jerry Silver, Regeneration and Plasticity; and Marie-Francoise
Chesselet, Transplantatiion and Repair. Section Editors and the Editor-in-Chief review each submission to determine whether the article
should be sent out for external review to shorten the review process and avoid unnecessary delays. The development of commentaries for
significant articles continues to be well received, and a series of Special Issues is drawing attention to emerging areas in neuroscience
of growing interest, including stem cells, pain and neuropathy, mitochondrial disorders, and brain stimulation for psychiatric disorders.
The turnaround time to first decision is now often less than one month (average 6 weeks), articles are posted to Science Direct as articles
in press within 2 months of acceptance. Medline / Pubmed now lists articles as soon as they appear on Science Direct. Please see also
the editorial from Sid Gilman from November
2005.
US National Institutes of Health (NIH) voluntary posting ("Public Access") policy
Experimental Neurology and Elsevier
facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company